Your browser doesn't support javascript.
Complementary dose of COVID-19 vaccination may prevent SARS-CoV-2 breakthrough infection among previously vaccinated HIV positive persons.
Kowalska, Justyna D; Bienkowski, Carlo; Firlag-Burkacka, Ewa; Skrzat-Klapaczynska, Agata.
  • Kowalska JD; Medical University of Warsaw, Department of Adults' Infectious Diseases.
  • Bienkowski C; HIV Out-patient Clinic, Hospital for Infectious Diseases in Warsaw, Poland.
  • Firlag-Burkacka E; Medical University of Warsaw, Department of Adults' Infectious Diseases.
  • Skrzat-Klapaczynska A; HIV Out-patient Clinic, Hospital for Infectious Diseases in Warsaw, Poland.
Przegl Epidemiol ; 76(2): 147-149, 2022.
Article in English | MEDLINE | ID: covidwho-2067617
ABSTRACT
People living with HIV (PLWH) are a heterogeneous group of immunocompromised persons. Detectable HIV viral load and chronic comorbidities are independently increasing the risk of severe outcomes from COVID-19 among PLWH. We aimed to assess the efficacy and safety of the COVID-19 vaccines in PLWH. A significant increase in S-RBD antibody titers >100 AU/mL was observed when compared the titers measured one week after the 1st dose to titers performed after the 2nd vaccine dose.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines / HIV Infections / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: Przegl Epidemiol Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines / HIV Infections / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: Przegl Epidemiol Year: 2022 Document Type: Article